Resistance to commonly used Antineoplastic Drugs An Upcoming Challenge
Abstract
No abstract
References
1. Sharma H L, Sharma K K. Chemotherapy of Neoplastic diseases. Principles of Pharmacology, Chapter 67, 2nd edition.2011;834-64.
2. Bruce AC, Philip CA, Brian JC et al. Antineoplastic agents. Chapter 51.Section IX-Chemotherapy of Neoplastic Diseases. Goodman & Gilman’s The Pharmacological Basis of Therapeutics-11th edition.
2006;1315-1404.
3. GoltesmanMM.Mechanism of Cancer Drug Resistance. Annual review medicine.2002; 53:615-27.
4. LongleyDB,Johnston PG. Molecular Mechanisms of Drug Resistance. Journal of Pathology. 2005; 205:275- 92.
5. TannokIF, LeeCMetal.Limited penetration of anticancer drugs through tumor tissue:a potential cause of resistance of solid tumors to chemotherapy. ClinicalCan Res2002;8:878-84.
6. Chorawala M R, Oza P M, Shah G B. Mechanism of Anticancer Drug Resistance: An Overview. Int J of pharmaceutical sciences and drug research. 2012;4(1):01-09.
7. Roskoski R. Jr. The ErB/HER Receptor Protein Tyrosine Kinases and Cancer.Biochem Biophys Res Commun. 2004; 319:1-11.
8. Gross ME, Shazer RL et al. Targeting the HER Kinase axis in cancer. Semin Oncol. 2004;31:9-20.
9. Bergman PJ. Mechanisms of anticancer drug resistance. Vet Clin North Am Small Anim Pract. 2003; 33(3):651-667.
10. Gergely S, Jill K et al. Targeting multidrug resistance in cancer. Nature Reviews. Drug Discovery. 2006;5:219- 34.
11. HananeAkhdar, Claire Legendre, Caroline Aninat and Fabrice More (2012). Anticancer Drug Metabolism: Chemotherapy Resistance and New Therapeutic Approaches, Topics on Drug Metabolism, Dr. James Paxton(Ed.), ISBN: 978-953-51-0099-7, InTech, Available from: http://www.intechopen.com/books/ topics-on-drugmetabolism/anticancer-drug-metabolism- chemotherapy-resistance-and-new-therapeutic- approaches.
12. Victor L. P glycoprotein and resistance to anticancer drugs. Cancer.2006; 69(10): 2603-09.
2. Bruce AC, Philip CA, Brian JC et al. Antineoplastic agents. Chapter 51.Section IX-Chemotherapy of Neoplastic Diseases. Goodman & Gilman’s The Pharmacological Basis of Therapeutics-11th edition.
2006;1315-1404.
3. GoltesmanMM.Mechanism of Cancer Drug Resistance. Annual review medicine.2002; 53:615-27.
4. LongleyDB,Johnston PG. Molecular Mechanisms of Drug Resistance. Journal of Pathology. 2005; 205:275- 92.
5. TannokIF, LeeCMetal.Limited penetration of anticancer drugs through tumor tissue:a potential cause of resistance of solid tumors to chemotherapy. ClinicalCan Res2002;8:878-84.
6. Chorawala M R, Oza P M, Shah G B. Mechanism of Anticancer Drug Resistance: An Overview. Int J of pharmaceutical sciences and drug research. 2012;4(1):01-09.
7. Roskoski R. Jr. The ErB/HER Receptor Protein Tyrosine Kinases and Cancer.Biochem Biophys Res Commun. 2004; 319:1-11.
8. Gross ME, Shazer RL et al. Targeting the HER Kinase axis in cancer. Semin Oncol. 2004;31:9-20.
9. Bergman PJ. Mechanisms of anticancer drug resistance. Vet Clin North Am Small Anim Pract. 2003; 33(3):651-667.
10. Gergely S, Jill K et al. Targeting multidrug resistance in cancer. Nature Reviews. Drug Discovery. 2006;5:219- 34.
11. HananeAkhdar, Claire Legendre, Caroline Aninat and Fabrice More (2012). Anticancer Drug Metabolism: Chemotherapy Resistance and New Therapeutic Approaches, Topics on Drug Metabolism, Dr. James Paxton(Ed.), ISBN: 978-953-51-0099-7, InTech, Available from: http://www.intechopen.com/books/ topics-on-drugmetabolism/anticancer-drug-metabolism- chemotherapy-resistance-and-new-therapeutic- approaches.
12. Victor L. P glycoprotein and resistance to anticancer drugs. Cancer.2006; 69(10): 2603-09.
Published
2019-09-12
How to Cite
Sharmada Nerlekar, Rashmi A, Avad P. (2019). Resistance to commonly used Antineoplastic Drugs An Upcoming Challenge. The Indian Practitioner, 67(7), 441-444. Retrieved from https://articles.theindianpractitioner.com/index.php/tip/article/view/784
Section
Review article
